Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y011019 | OT |
no adverse event; a 12-month year old child was administered VARIVAX intradermally; This spontaneous report was received from a medical assistant, referring to a 12-month-old female patient. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On 04-FEB-2025, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #Y011019, expiration date: 18-JUN-2026, administered intradermally for prophylaxis (dose and strength not provided) (product use issue), diluted with sterile diluent (MERCK STERILE DILUENT) solution for injection/infusion (strength, dose description, lot #, expiry date, and indication were not provided). No adverse side effects were reported (no adverse event).
MERCK STERILE DILUENT